Hypoxia reduces CD138 expression and induces an immature and stem cell-like transcriptional program in myeloma cells

By              

International Journal of Oncology, Vol. 43, Iss. 6, 2013-01 ,pp. : 1809-1816

Spandidos Publications

Access to resources Recommend Favorite

Current treatment strategies with lenalidomide in multiple myeloma and future perspectives

By Larocca Alessandra   Cavallo Federica   Mina Roberto   Boccadoro Mario   Palumbo Antonio  

Future Oncology, Vol. 8, Iss. 10, 2012-10 ,pp. : 1223-1238

Future Medicine

Access to resources Recommend Favorite

Activity and toxicity profiles of the combinations bendamustine–lenalidomide–dexamethasone and bendamustine–bortezomib–dexamethasone for advanced stage multiple myeloma

By Mele Giuseppe   Spina Alessandro   Guaragna Gianluca   Giannotta Angela   Melpignano Angela   Quarta Gianni  

Leukemia and Lymphoma, Vol. 55, Iss. 5, 2014-05 ,pp. : 1191-1193

Informa Healthcare

Access to resources Recommend Favorite

Long-term complete remission in a multiple myeloma patient after Stevens-Johnson syndrome due to lenalidomide therapy

By Musolino Caterina   Alonci Andrea   Catena Sara   Rizzotti Patricia   Russo Sabina   Rotondo Francesco   Allegra Alessandro  

Acta Oncologica, Vol. 52, Iss. 5, 2013-06 ,pp. : 1050-1051

Informa Healthcare

Access to resources Recommend Favorite

Successful treatment with lenalidomide of secondary multiple myeloma with extramedullary liver plasmacytoma in a renal transplant recipient: A case report and review of the literature

By                

Oncology Letters, Vol. 10, Iss. 5, 2015-01 ,pp. : 2931-2936

Spandidos Publications

Access to resources Recommend Favorite